Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Parathyroid Dysfunction: later-stage trial registry

1 of 2 indexed Parathyroid Dysfunction trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Parathyroid Dysfunction: 2 US clinical trials tracked, 1 recruiting.

Parathyroid Dysfunction is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Neurovision Medical Products, running 1 of these trials.

Enrollment posture brief

Registry condition parathyroid-dysfunction

OPEN 1 | RECR 50% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Parathyroid Dysfunction (thi…50%
Open-enrollment share among volume-matched conditions near Parathyroid Dysfunction

Parathyroid Dysfunction lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Parathyroid Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Parathyroid Dysfunction is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Parathyroid Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Parakeet:The Parakeet Rapid Parathyroid Testing Kit is a rapid immunoassay designed to detect Parathormone (PTH) in a test sample. Device
1 trials
SPY Portable Handheld Imaging Device
1 trials
Indocyanine green Drug
1 trials

US sites by state

Facility locations filed on Parathyroid Dysfunction trials. A trial with sites in several states counts in each.

California 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Parathyroid Dysfunction page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Parathyroid Dysfunction condition card totals 2 registered trials; most-linked intervention Parakeet:The Parakeet Rapid Parathyroid Testing Kit is a rapid immunoassay designed to detect Parathormone (PTH) in a test sample.; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.